Mon, May 23, 2011
Sun, May 22, 2011
Fri, May 20, 2011
Thu, May 19, 2011
Wed, May 18, 2011
Tue, May 17, 2011
Mon, May 16, 2011
Sun, May 15, 2011
[ Sun, May 15th 2011 ] - Market Wire
Teva to Acquire Taiyo
Fri, May 13, 2011
Thu, May 12, 2011
Wed, May 11, 2011
Tue, May 10, 2011
Mon, May 9, 2011
Sun, May 8, 2011
Sat, May 7, 2011
Fri, May 6, 2011
Thu, May 5, 2011
Wed, May 4, 2011
Tue, May 3, 2011
Mon, May 2, 2011
Fri, April 29, 2011
Thu, April 28, 2011
Wed, April 27, 2011
Tue, April 26, 2011
Mon, April 25, 2011

DaVita Continues to Lead Industry in Patient Vaccination Rates


//health-fitness.news-articles.net/content/2011/ .. -lead-industry-in-patient-vaccination-rates.html
Published in Health and Fitness on Tuesday, May 10th 2011 at 5:05 GMT by Market Wire   Print publication without navigation


DENVER--([ BUSINESS WIRE ])--[ DaVita Inc. ] (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the company exceeded its clinical goals for patient vaccination rates. The higher rate is a direct result of teammatesa™ and physiciansa™ education efforts with patients.

"I know that as a dialysis patient Ia™m at a greater risk to contract and spread these types of illnesses so I need to protect my health in any way I can."

aGetting my flu and pneumonia vaccinations was the best decision I could have made,a explains Ronnie Henderson, a dialysis patient at the DaVitaEast Aurorafacility. aI know that as a dialysis patient Ia™m at a greater risk to contract and spread these types of illnesses so I need to protect my health in any way I can.a

Based on the 2010 USRDS Annual Data Report (reporting claims-based data from 2008) the industry vaccination rates for influenza and pneumonia were 66.5 percent and 25.2 percent, respectively. Reporting from the same data, DaVitaa™s influenza vaccination rate was at 72.9 percent and its pneumonia vaccination rate was 36.4 percent for 2008. At the end of the first quarter of 2011, DaVita® internal tracking shows that it has vaccinated 90.9 percent of its patients for influenza and 90.4 percent of its patients for pneumonia.

aFlu vaccinations can be the difference between life and death for those suffering from CKD,a said DaVita Chief Medical Officer Dr. Allen R. Nissenson. aA sneeze is just a symptom to a healthy person but for a dialysis patient, it can be the sign of a life-threatening infection.a

Studies have shown that high vaccination rates relate directly to fewer hospitalizations, which can lead to a better quality of life for dialysis patients. Despite being challenged by an increase in number of patients since the beginning of this flu season, DaVita teammates and attending physicians, through a concerted effort, were able to achieve and maintain vaccination rates of 90 percent.

DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of March 31, 2011, DaVita operated or provided administrative services at 1,642 dialysis facilities, serving approximately 128,000 patients. DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. The companya™s leadership development initiatives and corporate social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu, among others. For more information, please visit [ www.davita.com ].


Publication Contributing Sources